← Eichor
Condition: Diffuse Parenchymal Lung Diseases Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Diffuse Parenchymal Lung Diseases

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Exercise Capacity, Muscle Oxygenation, and Physical Activity Between Patients With Interstitial Lung Disease
Phase N/A · 1 location(s) · Gazi University · NCT06948942Study to Evaluate Safety and Efficacy of Mirivadelgat in PH-ILD (Windward)
Phase 2 · 9 location(s) · Foresee Pharmaceuticals Co., Ltd. · NCT06475781Korean Idiopathic Pulmonary Fibrosis Registry
Phase N/A · 1 location(s) · Seoul National University Hospital · NCT04160715A Study to Evaluate Pharmacokinetics and Drug-drug Interactions of ENV-101 (Taladegib) in Healthy Participants
Phase 1 · 2 location(s) · Endeavor Biomedicines, Inc. · NCT07454291Evaluation of Efficacy and Safety of Rituximab in Patients With Progressive Interstitial Lung Disease (ILD) With Inflamm
Phase 3 · 1 location(s) · University Hospital, Tours · NCT05596786Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibrosis
Phase 2 · 1 location(s) · Peter Caravan · NCT07572383Database for Interstitial Lung Disease
Phase N/A · 1 location(s) · Medical University of Graz · NCT04707781FAPI PET for Lung Fibrosis
EARLY_Phase 1 · 1 location(s) · University of California, Los Angeles · NCT05365802Luvometinib in Pediatric SS-LCH With Special-site Single/Multifocal Bone Lesions
NA · 11 location(s) · West China Second University Hospital · NCT07371182Effect of HIgh-flow Therapy in Long-term Oxygen Therapy
NA · 2 location(s) · Skane University Hospital · NCT06247397Pneumoconiosis and Dust Exposure China Cohort
Phase N/A · 1 location(s) · China-Japan Friendship Hospital · NCT07077382Azithromycin in the Management of Patients With Acute Exacerbation of Idiopathic Pulmonary Fibrosis
NA · 2 location(s) · Assiut University · NCT05842681Evaluation of the Pulmonary Fibrosis Learning and Self-management Programme (FILIP)
NA · 2 location(s) · Insel Gruppe AG, University Hospital Bern · NCT07457463Screening of Patients With Rheumatoid Arthritis for Interstitial Lung Disease
Phase N/A · 3 location(s) · Polyclinic of the Hospitaller Brothers of St. John of God, B · NCT05391100DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease
Phase N/A · 67 location(s) · United Therapeutics · NCT06388421Prophylactic Inhaled Steroids to Reduce Radiation Pneumonitis Frequency and Severity in Lung Cancer Patients
Phase 2 · 2 location(s) · Instituto Nacional de Cancerologia de Mexico · NCT03803787Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) P
Phase 3 · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT07613099Efficacy of L-menthol on Breathlessness in Interstitial Lung Disease
Phase 2 · 2 location(s) · Region Skane · NCT07398287Interstitial Lung Disease: A Study From Infancy to Elderly Including Relatives
Phase N/A · 1 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT06036719A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of SV001 in Patients With Idi
Phase 2 · 12 location(s) · Shanghai Synvida Biotechnology Co.,Ltd. · NCT07121413Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associate
Phase 1 · 1 location(s) · IRIS Research and Development, LLC · NCT06581562Study on the Efficacy of Quercetin Intake in Patients With Fibrotic Interstitial Lung Diseases.
NA · 1 location(s) · Katerina M. Antoniou · NCT07466420H01 in Adults With Interstitial Lung Disease (The SOLIS Study)
Phase 2 · 1 location(s) · National Institute of Environmental Health Sciences (NIEHS) · NCT06325696SB17170 Phase 2 Trial in IPF Patients
Phase 2 · 5 location(s) · SPARK Biopharma · NCT06747923dEtection of rheumAtoid aRthritis - Interstitial Lung dIseasE by Thoracic ultRasound
Phase N/A · 1 location(s) · University Hospital, Tours · NCT06235645REspiratory diSEAse cohoRt Studies of CHinese Medicine for ILD (RESEARCH-ILD)
Phase N/A · 1 location(s) · Henan University of Traditional Chinese Medicine · NCT06577753A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Jap
Phase 1 · 28 location(s) · GlaxoSmithKline · NCT06576271A Multicenter Prospective Study of Risk Factors in Progressive Pulmonary Fibrosis
Phase N/A · 1 location(s) · Qianfoshan Hospital · NCT05895409Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Phase 3 · 165 location(s) · United Therapeutics · NCT05943535Connective Tissue Diseases and Lung Manifestations
Phase N/A · 1 location(s) · Medical University Innsbruck · NCT04095351
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.